Peijia Medical Limited signed a memorandum of strategic cooperation with China Resources Pharmaceutical Commercial Group Medical Devices Co. Ltd. on June 2. Going forward, the two parties will collaborate intensively on the commercialization of TAVR products, ultimately providing more Chinese medical staff and patients with better quality goods. The signing ceremony included a series of speeches by Chen Wei (CR PHARMA COMM Chairman), Tang Yanlin, (CR PHARMA COMM Executive Deputy General Manager), and Karen Xiaoxiao Zhuang (Peijia Medical Director of Sales), respectively. After each company introduced its current business development, they got into the details of the cooperation, exchanging a great range of information and ideas on regional downstream and terminal business models.